Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Proteomics International Laboratories Ltd. ( (AU:PIQ) ) has shared an update.
Proteomics International Laboratories Ltd has announced a change in the director’s interest, specifically involving Dr. Richard Lipscombe. The change includes the acquisition of additional ordinary shares and options, following shareholder approval at an extraordinary general meeting. This development reflects the company’s ongoing strategic initiatives to enhance its market position and align its leadership’s interests with those of its stakeholders.
The most recent analyst rating on (AU:PIQ) stock is a Sell with a A$0.50 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd is a company operating in the biotechnology industry, focusing on the development and commercialization of diagnostic tests and analytical services. The company is known for its expertise in proteomics, which involves the large-scale study of proteins, and it aims to provide innovative solutions for healthcare and research sectors.
Average Trading Volume: 172,902
Technical Sentiment Signal: Sell
Current Market Cap: A$63.77M
For a thorough assessment of PIQ stock, go to TipRanks’ Stock Analysis page.